Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
5.27
+0.02 (0.38%)
Nov 17, 2026, 3:00 PM CST
SHA:600998 Revenue
Jointown Pharmaceutical Group had revenue of 42.17B CNY in the quarter ending September 30, 2026, with 10.32% growth. This brings the company's total for the last twelve months to 171.51B, up 8.75% year-over-year. In the year 2025, Jointown Pharmaceutical Group had annual revenue of 161.39B with 6.31% growth. That makes Jointown Pharmaceutical Group the 575th largest company in the world by revenue and 46th in China.
Revenue (ttm)
171.51B
Revenue Growth
+8.75%
P/S Ratio
0.15
Revenue / Employee
5.74M
Employees
29,862
Market Cap
26.28B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600998 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 161.39B | 9.58B | 6.31% |
| Dec 31, 2024 | 151.81B | 1.67B | 1.11% |
| Dec 31, 2023 | 150.14B | 9.72B | 6.92% |
| Dec 31, 2022 | 140.42B | 18.02B | 14.72% |
| Dec 31, 2021 | 122.41B | 11.55B | 10.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsJointown Pharmaceutical Group News
- 24 days ago - Jointown Pharmaceutical Group Quarterly report: Q3 2026 - Filings
- 2 months ago - Jointown Pharmaceutical Group Quarterly report: Q2 2026 - Filings
- 6 months ago - Jointown Pharmaceutical Group Quarterly report: Q1 2026 - Filings
- 6 months ago - Jointown Pharmaceutical Group Annual report: Q4 2025 - Filings